Abstract:P2X receptors are extracellular ATP-gated ion channels that form homo-or heterotrimers and consist of seven subtypes. They are expressed in various tissues, including neuronal and nonneuronal cells, and play critical roles in physiological processes such as neurotransmission, inflammation, pain, and cancer. As a result, P2X receptors have attracted considerable interest as drug targets, and various competitive inhibitors have been developed. However, although several P2X receptor structures from different subtypes have been reported, the limited structural information of P2X receptors in complex with competitive antagonists hampers the understanding of orthosteric inhibition, hindering the further design and optimization of those antagonists for drug discovery. Here, we determined the cryo-EM structures of the mammalian P2X7 receptor in complex with two classical competitive antagonists of pyridoxal-5’-phosphate derivatives, PPNDS and PPADS, at 3.3 and 3.6 Å resolution, respectively, and performed structure-based mutational analysis by patch-clamp recording as well as MD simulations. Our structures revealed the orthosteric site for PPADS/PPNDS, and structural comparison with the previously reported apo-and ATP-bound structures showed how PPADS/PPNDS binding inhibits the conformational changes associated with channel activation. In addition, structure-based mutational analysis identified key residues involved in the PPNDS sensitivity of P2X1 and P2X3, which are known to have higher affinity for PPADS/PPNDS than other P2X subtypes. Overall, our work provides structural insights into the orthosteric inhibition and subtype specificity of P2X receptors by the classical P2X antagonists, pyridoxal-5’-phosphate derivatives, thereby facilitating the rational design of novel competitive antagonists for P2X receptors.

Structural basis for the functional properties of the P2X7 receptor for extracellular ATP

Ionotropic purinergic receptor 7 (P2X7) channel structure and pharmacology provides insight regarding non-nucleotide agonism

Principles and properties of ion flow in P2X receptors.

Structure, Function and Disease Associations

Molecular Mechanisms of Human P2X3 Receptor Channel Activation and Modulation by Divalent Cation Bound ATP

The P2X7 Purinergic Receptor: an Emerging Therapeutic Target in Cardiovascular Diseases

Molecular Mechanism of ATP Binding and Ion Channel Activation in P2X Receptors

Recent progress in the structural biology of P2X receptors

Structural Insights into the Nucleotide Base Specificity of P2X Receptors

P2x(7) Receptors: Properties And Relevance To Cns Function

P2X7 receptors exhibit at least three modes of allosteric antagonism

Structural Insights into the Competitive Inhibition of the ATP-gated P2X Receptor Channel

P2X7 receptor in multifaceted cellular signalling and its relevance as a potential therapeutic target in different diseases

Structural Insights into Divalent Cation Modulations of ATP-Gated P2X Receptor Channels.

Potential therapeutic targets for ATP-gated P2X receptor ion channels.

Structural insights into the orthosteric inhibition of P2X receptors by non-ATP-analog antagonists

Structural insights into the orthosteric inhibition of P2X receptors by non-ATP analog antagonists

The P2X<sub>1</sub>ion channel in platelet function

Structural insights into the human P2X1 receptor and ligand interactions

Regulation of Immune Response by P2X7 Receptor.

Full-Length P2X7 Structures Reveal How Palmitoylation Prevents Channel Desensitization